Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-5 of 5 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia

    Rochester, MN

  2. A Study Of LY4152199 In Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    Rochester, MN

  3. Study Of KITE-363 Or KITE-753 In Participants With Relapsed And/or Refractory B-cell Lymphoma

    Jacksonville, FL, Rochester, MN

  4. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL

    Rochester, MN

  5. Gene Therapy For B-Cell Acute Lymphoblastic Leukemia

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer